カテゴリー： 世界, 医療/バイオ, QYResearch

ネオエンドルフィンの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Neo-Endorphin Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX09258）・商品コード：QY22JLX09258
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：89
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、ネオエンドルフィンのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にネオエンドルフィンの世界市場のxxx％を占める「α-ネオエンドルフィン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「科学研究」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ネオエンドルフィンの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのネオエンドルフィン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ネオエンドルフィンのグローバル主要企業には、Peptide Institute、Abbexa、Elabscience、Biosynth Carbosynth、Generon.co.uk、Phoenix Pharmaceuticals、Creative Peptidesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ネオエンドルフィン市場は、種類と用途によって区分されます。世界のネオエンドルフィン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
α-ネオエンドルフィン、β-ネオエンドルフィン

【用途別セグメント】
科学研究、医療、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ネオエンドルフィン製品概要
- 種類別市場（α-ネオエンドルフィン、β-ネオエンドルフィン）
- 用途別市場（科学研究、医療、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のネオエンドルフィン販売量予測2017-2028
- 世界のネオエンドルフィン売上予測2017-2028
- ネオエンドルフィンの地域別販売量
- ネオエンドルフィンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ネオエンドルフィン販売量
- 主要メーカー別ネオエンドルフィン売上
- 主要メーカー別ネオエンドルフィン価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（α-ネオエンドルフィン、β-ネオエンドルフィン）
- ネオエンドルフィンの種類別販売量
- ネオエンドルフィンの種類別売上
- ネオエンドルフィンの種類別価格
・用途別市場規模（科学研究、医療、その他）
- ネオエンドルフィンの用途別販売量
- ネオエンドルフィンの用途別売上
- ネオエンドルフィンの用途別価格
・北米市場
- 北米のネオエンドルフィン市場規模（種類別、用途別）
- 主要国別のネオエンドルフィン市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのネオエンドルフィン市場規模（種類別、用途別）
- 主要国別のネオエンドルフィン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のネオエンドルフィン市場規模（種類別、用途別）
- 主要国別のネオエンドルフィン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のネオエンドルフィン市場規模（種類別、用途別）
- 主要国別のネオエンドルフィン市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのネオエンドルフィン市場規模（種類別、用途別）
- 主要国別のネオエンドルフィン市場規模（トルコ、サウジアラビア）
・企業情報
Peptide Institute、Abbexa、Elabscience、Biosynth Carbosynth、Generon.co.uk、Phoenix Pharmaceuticals、Creative Peptides
・産業チェーン及び販売チャネル分析
- ネオエンドルフィンの産業チェーン分析
- ネオエンドルフィンの原材料
- ネオエンドルフィンの生産プロセス
- ネオエンドルフィンの販売及びマーケティング
- ネオエンドルフィンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ネオエンドルフィンの産業動向
- ネオエンドルフィンのマーケットドライバー
- ネオエンドルフィンの課題
- ネオエンドルフィンの阻害要因
・主な調査結果

Market Analysis and Insights: Global Neo-Endorphin Market
The global Neo-Endorphin market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, α-Neo-Endorphin accounting for % of the Neo-Endorphin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Scientific Research segment is altered to an % CAGR throughout this forecast period.
China Neo-Endorphin market size is valued at US$ million in 2021, while the North America and Europe Neo-Endorphin are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Neo-Endorphin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neo-Endorphin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neo-Endorphin market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neo-Endorphin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neo-Endorphin market.
Global Neo-Endorphin Scope and Market Size
Neo-Endorphin market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Neo-Endorphin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
α-Neo-Endorphin
β-Neo-Endorphin
Segment by Application
Scientific Research
Medical
Others
By Company
Peptide Institute
Abbexa
Elabscience
Biosynth Carbosynth
Generon.co.uk
Phoenix Pharmaceuticals
Creative Peptides
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neo-Endorphin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 α-Neo-Endorphin
1.2.3 β-Neo-Endorphin
1.3 Market by Application
1.3.1 Global Neo-Endorphin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neo-Endorphin Market Perspective (2017-2028)
2.2 Neo-Endorphin Growth Trends by Region
2.2.1 Neo-Endorphin Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Neo-Endorphin Historic Market Size by Region (2017-2022)
2.2.3 Neo-Endorphin Forecasted Market Size by Region (2023-2028)
2.3 Neo-Endorphin Market Dynamics
2.3.1 Neo-Endorphin Industry Trends
2.3.2 Neo-Endorphin Market Drivers
2.3.3 Neo-Endorphin Market Challenges
2.3.4 Neo-Endorphin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neo-Endorphin Players by Revenue
3.1.1 Global Top Neo-Endorphin Players by Revenue (2017-2022)
3.1.2 Global Neo-Endorphin Revenue Market Share by Players (2017-2022)
3.2 Global Neo-Endorphin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neo-Endorphin Revenue
3.4 Global Neo-Endorphin Market Concentration Ratio
3.4.1 Global Neo-Endorphin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neo-Endorphin Revenue in 2021
3.5 Neo-Endorphin Key Players Head office and Area Served
3.6 Key Players Neo-Endorphin Product Solution and Service
3.7 Date of Enter into Neo-Endorphin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neo-Endorphin Breakdown Data by Type
4.1 Global Neo-Endorphin Historic Market Size by Type (2017-2022)
4.2 Global Neo-Endorphin Forecasted Market Size by Type (2023-2028)
5 Neo-Endorphin Breakdown Data by Application
5.1 Global Neo-Endorphin Historic Market Size by Application (2017-2022)
5.2 Global Neo-Endorphin Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Neo-Endorphin Market Size (2017-2028)
6.2 North America Neo-Endorphin Market Size by Type
6.2.1 North America Neo-Endorphin Market Size by Type (2017-2022)
6.2.2 North America Neo-Endorphin Market Size by Type (2023-2028)
6.2.3 North America Neo-Endorphin Market Share by Type (2017-2028)
6.3 North America Neo-Endorphin Market Size by Application
6.3.1 North America Neo-Endorphin Market Size by Application (2017-2022)
6.3.2 North America Neo-Endorphin Market Size by Application (2023-2028)
6.3.3 North America Neo-Endorphin Market Share by Application (2017-2028)
6.4 North America Neo-Endorphin Market Size by Country
6.4.1 North America Neo-Endorphin Market Size by Country (2017-2022)
6.4.2 North America Neo-Endorphin Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Neo-Endorphin Market Size (2017-2028)
7.2 Europe Neo-Endorphin Market Size by Type
7.2.1 Europe Neo-Endorphin Market Size by Type (2017-2022)
7.2.2 Europe Neo-Endorphin Market Size by Type (2023-2028)
7.2.3 Europe Neo-Endorphin Market Share by Type (2017-2028)
7.3 Europe Neo-Endorphin Market Size by Application
7.3.1 Europe Neo-Endorphin Market Size by Application (2017-2022)
7.3.2 Europe Neo-Endorphin Market Size by Application (2023-2028)
7.3.3 Europe Neo-Endorphin Market Share by Application (2017-2028)
7.4 Europe Neo-Endorphin Market Size by Country
7.4.1 Europe Neo-Endorphin Market Size by Country (2017-2022)
7.4.2 Europe Neo-Endorphin Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neo-Endorphin Market Size (2017-2028)
8.2 Asia-Pacific Neo-Endorphin Market Size by Type
8.2.1 Asia-Pacific Neo-Endorphin Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Neo-Endorphin Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Neo-Endorphin Market Share by Type (2017-2028)
8.3 Asia-Pacific Neo-Endorphin Market Size by Application
8.3.1 Asia-Pacific Neo-Endorphin Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Neo-Endorphin Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Neo-Endorphin Market Share by Application (2017-2028)
8.4 Asia-Pacific Neo-Endorphin Market Size by Region
8.4.1 Asia-Pacific Neo-Endorphin Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Neo-Endorphin Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neo-Endorphin Market Size (2017-2028)
9.2 Latin America Neo-Endorphin Market Size by Type
9.2.1 Latin America Neo-Endorphin Market Size by Type (2017-2022)
9.2.2 Latin America Neo-Endorphin Market Size by Type (2023-2028)
9.2.3 Latin America Neo-Endorphin Market Share by Type (2017-2028)
9.3 Latin America Neo-Endorphin Market Size by Application
9.3.1 Latin America Neo-Endorphin Market Size by Application (2017-2022)
9.3.2 Latin America Neo-Endorphin Market Size by Application (2023-2028)
9.3.3 Latin America Neo-Endorphin Market Share by Application (2017-2028)
9.4 Latin America Neo-Endorphin Market Size by Country
9.4.1 Latin America Neo-Endorphin Market Size by Country (2017-2022)
9.4.2 Latin America Neo-Endorphin Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neo-Endorphin Market Size (2017-2028)
10.2 Middle East & Africa Neo-Endorphin Market Size by Type
10.2.1 Middle East & Africa Neo-Endorphin Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Neo-Endorphin Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Neo-Endorphin Market Share by Type (2017-2028)
10.3 Middle East & Africa Neo-Endorphin Market Size by Application
10.3.1 Middle East & Africa Neo-Endorphin Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Neo-Endorphin Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Neo-Endorphin Market Share by Application (2017-2028)
10.4 Middle East & Africa Neo-Endorphin Market Size by Country
10.4.1 Middle East & Africa Neo-Endorphin Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Neo-Endorphin Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Peptide Institute
11.1.1 Peptide Institute Company Details
11.1.2 Peptide Institute Business Overview
11.1.3 Peptide Institute Neo-Endorphin Introduction
11.1.4 Peptide Institute Revenue in Neo-Endorphin Business (2017-2022)
11.1.5 Peptide Institute Recent Developments
11.2 Abbexa
11.2.1 Abbexa Company Details
11.2.2 Abbexa Business Overview
11.2.3 Abbexa Neo-Endorphin Introduction
11.2.4 Abbexa Revenue in Neo-Endorphin Business (2017-2022)
11.2.5 Abbexa Recent Developments
11.3 Elabscience
11.3.1 Elabscience Company Details
11.3.2 Elabscience Business Overview
11.3.3 Elabscience Neo-Endorphin Introduction
11.3.4 Elabscience Revenue in Neo-Endorphin Business (2017-2022)
11.3.5 Elabscience Recent Developments
11.4 Biosynth Carbosynth
11.4.1 Biosynth Carbosynth Company Details
11.4.2 Biosynth Carbosynth Business Overview
11.4.3 Biosynth Carbosynth Neo-Endorphin Introduction
11.4.4 Biosynth Carbosynth Revenue in Neo-Endorphin Business (2017-2022)
11.4.5 Biosynth Carbosynth Recent Developments
11.5 Generon.co.uk
11.5.1 Generon.co.uk Company Details
11.5.2 Generon.co.uk Business Overview
11.5.3 Generon.co.uk Neo-Endorphin Introduction
11.5.4 Generon.co.uk Revenue in Neo-Endorphin Business (2017-2022)
11.5.5 Generon.co.uk Recent Developments
11.6 Phoenix Pharmaceuticals
11.6.1 Phoenix Pharmaceuticals Company Details
11.6.2 Phoenix Pharmaceuticals Business Overview
11.6.3 Phoenix Pharmaceuticals Neo-Endorphin Introduction
11.6.4 Phoenix Pharmaceuticals Revenue in Neo-Endorphin Business (2017-2022)
11.6.5 Phoenix Pharmaceuticals Recent Developments
11.7 Creative Peptides
11.7.1 Creative Peptides Company Details
11.7.2 Creative Peptides Business Overview
11.7.3 Creative Peptides Neo-Endorphin Introduction
11.7.4 Creative Peptides Revenue in Neo-Endorphin Business (2017-2022)
11.7.5 Creative Peptides Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Neo-Endorphin Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of α-Neo-Endorphin
Table 3. Key Players of β-Neo-Endorphin
Table 4. Global Neo-Endorphin Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Neo-Endorphin Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Neo-Endorphin Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Neo-Endorphin Market Share by Region (2017-2022)
Table 8. Global Neo-Endorphin Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Neo-Endorphin Market Share by Region (2023-2028)
Table 10. Neo-Endorphin Market Trends
Table 11. Neo-Endorphin Market Drivers
Table 12. Neo-Endorphin Market Challenges
Table 13. Neo-Endorphin Market Restraints
Table 14. Global Neo-Endorphin Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Neo-Endorphin Revenue Share by Players (2017-2022)
Table 16. Global Top Neo-Endorphin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neo-Endorphin as of 2021)
Table 17. Ranking of Global Top Neo-Endorphin Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Neo-Endorphin Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neo-Endorphin Product Solution and Service
Table 21. Date of Enter into Neo-Endorphin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neo-Endorphin Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Neo-Endorphin Revenue Market Share by Type (2017-2022)
Table 25. Global Neo-Endorphin Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Neo-Endorphin Revenue Market Share by Type (2023-2028)
Table 27. Global Neo-Endorphin Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Neo-Endorphin Revenue Share by Application (2017-2022)
Table 29. Global Neo-Endorphin Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Neo-Endorphin Revenue Share by Application (2023-2028)
Table 31. North America Neo-Endorphin Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Neo-Endorphin Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Neo-Endorphin Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Neo-Endorphin Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Neo-Endorphin Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Neo-Endorphin Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Neo-Endorphin Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Neo-Endorphin Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Neo-Endorphin Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Neo-Endorphin Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Neo-Endorphin Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Neo-Endorphin Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Neo-Endorphin Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Neo-Endorphin Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Neo-Endorphin Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Neo-Endorphin Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Neo-Endorphin Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Neo-Endorphin Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Neo-Endorphin Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Neo-Endorphin Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Neo-Endorphin Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Neo-Endorphin Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Neo-Endorphin Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Neo-Endorphin Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Neo-Endorphin Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Neo-Endorphin Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Neo-Endorphin Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Neo-Endorphin Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Neo-Endorphin Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Neo-Endorphin Market Size by Country (2023-2028) & (US$ Million)
Table 61. Peptide Institute Company Details
Table 62. Peptide Institute Business Overview
Table 63. Peptide Institute Neo-Endorphin Product
Table 64. Peptide Institute Revenue in Neo-Endorphin Business (2017-2022) & (US$ Million)
Table 65. Peptide Institute Recent Developments
Table 66. Abbexa Company Details
Table 67. Abbexa Business Overview
Table 68. Abbexa Neo-Endorphin Product
Table 69. Abbexa Revenue in Neo-Endorphin Business (2017-2022) & (US$ Million)
Table 70. Abbexa Recent Developments
Table 71. Elabscience Company Details
Table 72. Elabscience Business Overview
Table 73. Elabscience Neo-Endorphin Product
Table 74. Elabscience Revenue in Neo-Endorphin Business (2017-2022) & (US$ Million)
Table 75. Elabscience Recent Developments
Table 76. Biosynth Carbosynth Company Details
Table 77. Biosynth Carbosynth Business Overview
Table 78. Biosynth Carbosynth Neo-Endorphin Product
Table 79. Biosynth Carbosynth Revenue in Neo-Endorphin Business (2017-2022) & (US$ Million)
Table 80. Biosynth Carbosynth Recent Developments
Table 81. Generon.co.uk Company Details
Table 82. Generon.co.uk Business Overview
Table 83. Generon.co.uk Neo-Endorphin Product
Table 84. Generon.co.uk Revenue in Neo-Endorphin Business (2017-2022) & (US$ Million)
Table 85. Generon.co.uk Recent Developments
Table 86. Phoenix Pharmaceuticals Company Details
Table 87. Phoenix Pharmaceuticals Business Overview
Table 88. Phoenix Pharmaceuticals Neo-Endorphin Product
Table 89. Phoenix Pharmaceuticals Revenue in Neo-Endorphin Business (2017-2022) & (US$ Million)
Table 90. Phoenix Pharmaceuticals Recent Developments
Table 91. Creative Peptides Company Details
Table 92. Creative Peptides Business Overview
Table 93. Creative Peptides Neo-Endorphin Product
Table 94. Creative Peptides Revenue in Neo-Endorphin Business (2017-2022) & (US$ Million)
Table 95. Creative Peptides Recent Developments
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neo-Endorphin Market Share by Type: 2021 VS 2028
Figure 2. α-Neo-Endorphin Features
Figure 3. β-Neo-Endorphin Features
Figure 4. Global Neo-Endorphin Market Share by Application: 2021 VS 2028
Figure 5. Scientific Research Case Studies
Figure 6. Medical Case Studies
Figure 7. Others Case Studies
Figure 8. Neo-Endorphin Report Years Considered
Figure 9. Global Neo-Endorphin Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Neo-Endorphin Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Neo-Endorphin Market Share by Region: 2021 VS 2028
Figure 12. Global Neo-Endorphin Market Share by Players in 2021
Figure 13. Global Top Neo-Endorphin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neo-Endorphin as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Neo-Endorphin Revenue in 2021
Figure 15. North America Neo-Endorphin Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Neo-Endorphin Market Size Market Share by Type (2017-2028)
Figure 17. North America Neo-Endorphin Market Size Market Share by Application (2017-2028)
Figure 18. North America Neo-Endorphin Market Size Share by Country (2017-2028)
Figure 19. United States Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Neo-Endorphin Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Neo-Endorphin Market Size Market Share by Type (2017-2028)
Figure 23. Europe Neo-Endorphin Market Size Market Share by Application (2017-2028)
Figure 24. Europe Neo-Endorphin Market Size Share by Country (2017-2028)
Figure 25. Germany Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Neo-Endorphin Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Neo-Endorphin Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Neo-Endorphin Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Neo-Endorphin Market Size Share by Region (2017-2028)
Figure 35. China Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Neo-Endorphin Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Neo-Endorphin Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Neo-Endorphin Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Neo-Endorphin Market Size Share by Country (2017-2028)
Figure 45. Mexico Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Neo-Endorphin Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Neo-Endorphin Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Neo-Endorphin Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Neo-Endorphin Market Size Share by Country (2017-2028)
Figure 51. Turkey Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Neo-Endorphin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Peptide Institute Revenue Growth Rate in Neo-Endorphin Business (2017-2022)
Figure 55. Abbexa Revenue Growth Rate in Neo-Endorphin Business (2017-2022)
Figure 56. Elabscience Revenue Growth Rate in Neo-Endorphin Business (2017-2022)
Figure 57. Biosynth Carbosynth Revenue Growth Rate in Neo-Endorphin Business (2017-2022)
Figure 58. Generon.co.uk Revenue Growth Rate in Neo-Endorphin Business (2017-2022)
Figure 59. Phoenix Pharmaceuticals Revenue Growth Rate in Neo-Endorphin Business (2017-2022)
Figure 60. Creative Peptides Revenue Growth Rate in Neo-Endorphin Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed


★調査レポート[ネオエンドルフィンの世界市場インサイト・予測（～2028年）] (コード：QY22JLX09258)販売に関する免責事項を必ずご確認ください。
★調査レポート[ネオエンドルフィンの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • アジュバントペプチドの世界市場インサイト・予測（～2028年）
  • 結膜炎治療の世界市場インサイト・予測（～2028年）
  • ダラツムマブ注射の世界市場インサイト・予測（～2028年）
  • デノスマブの世界市場インサイト・予測（～2028年）
  • マイオビューの世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆